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The influence of islet-activating protein (IAP), a Bordetella pertussis toxin, was studied on adenylate 
cyclase and GTPase activities in rat adipocyte membranes. Pretreatment of rats or intact rat adipocytes 
with IAP did not affect adenylate cyclase inhibition by the stable GTP analog, GTP$$ whereas inhibition 
by GTP was abolished. Concomitantly, activation of the adipocyte nzyme by sodium and its inhibition 
by nicotinic acid were prevented. Furthermore, IAP treatment of adipocyte membranes prevented nicotinic 
acid-induced stimulation of a high affinity GTPase. The data suggest that a GTP-hydrolyzing system 
involved in the inhibitory regulation of adenylate cyclase is the target of IAP’s action. 
Islet-activating protein Bordetella pertussis toxin Rat adipocyte Adenylate cyclase 
G TPase 
1. INTRODUCTION 
1slet:activating protein (IAP), a Bordefella per- 
tussis’ioxin, modulates adenylate cyclase activity 
probably. by an ADP-ribosylation of a regulatory 
component of the adenylate cyclase system. The 
target of’the ADP-ribosylation reaction caused by 
IAP is distinct from the guanine nucleotide- 
binding regulatory site, that is ADP-ribosylated by 
cholera toxin and that is involved in adenylate 
cyclase stimulation by hormones [1,2]. Since 
hormone-induced inhibition of adenylate cyclase 
(e.g., by a-adrenergic agonists in pancreatic cells 
[3] or by muscarinic choline& agonists in heart 
cells [4]) is impaired or abolished by IAP, it is 
feasible that the site affected by IAP is functional- 
ly involved in the negative control of adenylate 
cyclase activity. 
Adipocyte adenylate cyclase is inhibited by 
various hormonal factors such as prostaglandin 
El, adenosine or nicotinic acid by a GTP- 
dependent process [5-71. Additionally, the 
adipocyte enzyme can be inhibited by GTP itself 
and by stable GTP analogs such as guanyl 5 ’ -yl- 
Nicotinic acid 
imidodiphosphate and guanosine 5 ’ -O- 
(3-thiotriphosphate) (GTP-S) [8,9]. Hormonal fac- 
tors that inhibit adenylate cyclase stimulate a high 
affinity GTPase in adipocyte membranes, which is 
not affected by cholera toxin [lO,ll]. There ap- 
peared to be a close connection between adenylate 
cyclase inhibition and GTPase stimulation. To fur- 
ther elucidate the role of IAP in the inhibitory 
regulation of adenylate cyclase, the influence of 
IAP was studied on guanine nucleotide and 
nicotinic acid-induced rat adipocyte adenylate 
cyclase inhibition and on nicotinic acid-induced 
GTPase stimulation. We report here that IAP 
treatment impairs or abolishes inhibition of 
adenylate cyclase by GTP and nicotinic acid, 
whereas the inhibitory effect of GTPyS is not af- 
fected by the toxin, and that IAP can prevent the 
nicotinic acid-induced GTPase stimulation. 
2. MATERIALS AND METHODS 
2.1. Materials 
The IAP used was partially purified on hydr- 
oxyapatite columns or purified to apparent 
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homogeneity by subsequent chromatography on 
haptoglobin-Sepharose as. in [12] from the super- 
natant of B. perfussis uspensions kindly provided 
by Drs L. Robbel and F. Blackkolb, Behringwerke 
(Marburg). Forskolin was donated by Dr H. Met- 
zger, Hoechst AG (Frankfurt). Other materials us- 
ed were as in [7,9]. 
2.2. IAP treatment 
Male rats (180-220 g) were treated once with 
30-100/11 (i.v.) of partially purified IAP 
(1 mg/ml). Three days later, the rats were killed by 
decapitation, and adipocyte ghosts were prepared 
as in [7]. For pretreatment of adipocytes with IAP, 
intact rat adipocytes (1 ml of packed cell suspen- 
sion) were incubated in the medium used for 
adipocyte isolation [7] for l-3 h at 30°C with and 
without 100 ,~l partially purified IAP. Thereafter, 
the cells were lysed and adipocyte ghosts were 
prepared [7]. For pretreatment of rat adipocyte 
ghosts with IAP, the incubation medium contained 
in 200~1 final vol. 5 mM MgC12, 10 mM 
thymidine, 0.5 mM NAD, 0.5 mM ATP, 5 mM 
creatine phosphate, 0.4 mg/ml creatine kinase, 
2 mg/ml bovine serum albumin, 50 mM 
triethanolamine-HCl (pH 7.4) and purified IAP at 
the indicated concentrations. The pretreatment 
was for 10 min at 37°C. Thereafter, the mem- 
branes were pelleted by centrifugation for 4 min at 
10000 x g and 4”C, once washed with 1 ml of 
10 mM triethanolamine-HCl (pH 7.4) and 
resuspended in 1 mM KHCO3 for GTPase assay. 
2.3. Adenylate cyclase and GTPase assays 
Adenylate cyclase activity was determined as in 
[9] with 50 /tM [~u-~~P]ATP (-0.4 &X/tube), 
2 mM MgClz, 0.1 mM cyclic AMP, 1 mM 
3-isobutyl-1-methylxanthine, 5mM creatine 
phosphate, 0.4 mg/ml creatine kinase, 2 mg/ml 
bovine serum albumin and 50 mM 
triethanolamine-HCl (pH 7.4) in 100 ~1 total vol. 
Reactions were initiated by the addition of 
adipocyte ghosts (5-30,ug protein/tube) and con- 
ducted for 10 min at 25°C. Cyclic AMP formed 
was isolated as in [13]. GTPase activity was deter- 
mined as in [lo] with essentially the same reaction 
mixture as used for adenylate cyclase assay, with 
the exception that 0.5 PM [Y-‘~P]GTP 
(-0.1 &i/tube), 0.1 mM unlabeled ATP, 3 mM 
adenyl 5 ’ -yl-imidodiphosphate, 0.1 mM EDTA 
and 100 mM NaCl were present. Incubation with 
adipocyte ghosts (2-10,ug protein/tube) was for 
10 min at 25°C. Specific, low Km GTPase activity 
was determined as in [lo]. 
3. RESULTS 
In adipocyte ghosts from control rats, GTP in- 
hibited the forskolin (50 FM)-stimulated adenylate 
cyclase by maximally about 50070, with half- 
maximal inhibition occurring at about 0.2 FM 
GTP (fig.1). Similar to that described for hamster 
adipocytes [9] and cyc- variants of S49 lymphoma 
cells 114,151, the rat adipocyte adenylate cyclase 
stimulated by forskolin was inhibited by the stable 
GTP analog, GTP+, much more potently than by 
GTP. Whereas GTPyS caused the same maximal 
degree of inhibition as observed with GTP, haIf- 
maximal inhibition was obtained with only 5 nM 
GTPyS. In adipocyte ghosts from IAP-pretreated 
rats, GTPyS caused a similar adenylate cyclase in- 
hibition as observed in control adipocytes, both 
with regard to the degree of enzyme inhibition and 
to the concentration required for half-maximal ef- 
fect. In contrast, inhibition of the adenylate 
cyclase by GTP was almost completely abolished 
in adipocyte ghosts of IAP-pretreated rats. Similar 
results were obtained when intact rat adipocyties 
were pretreated with IAP (fig.2). After incubation 
of intact rat adipocytes for l-3 h in the absence of 
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Fig. 1. Influence of in vivo treatment of rats with IAP on 
guanine nucleotide-induced adipocyte adenylate cyclase 
inhibition. Adipocyte ghosts were prepared from rats 
pretreated without (control, left panel) and with 
partially purified IAP (right panel) as described in 
section 2. Adenylate cyclase activity was determined in
the presence of 50,&l forskolin at increasing 
concentrations of GTP or GTPyS as indicated. 
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Fig.2. Influence of IAP treatment of intact rat 
adipocytes on guanine nucleotide-induced a enylate 
cyclase in~bition. Intact rat adipocytes were pretreated 
for 1, 2 or 3 h without (control, right panel) and with 
partially purified IAP (left panel) as in section 2. In 
adipocyte ghosts prepared thereof, adenylate cyclase 
activity was determined in the presence of SO yM 
forskdin without and with 1 pcM GTP or 0.1 ,uM GTPyS 
as indicated. Enzyme activity is given as % of control 
activity measured without GTP or GTPrS. 
IAP, adenyfate cyclase inhibition by GTP (I PM) 
and GTP$S (0.1 FM) was even slightly increased. 
The presence of IAP in the preincubation medium 
did not affect he GTP~S-induced inhibition of the 
forskolin (50 PM)-stimulated enzyme. In contrast, 
the IAP pretreatment reversed the GTP-induced 
inhibition in a time-dependent manner. After in- 
cubation for 2 h, the inhibition was largely reduc- 
ed, and after 3 h GTP even caused asmall increase 
in enzyme activity. 
Pretreatment of rats with IAP did not only im- 
pair GTP-induced adenylate cyclase inhibition but 
also the inhibition of the adipocyte enzyme by 
nicotinic acid, which has been shown to inhibit the 
adipocyte adenylate cyclase in a hormone-like 
manner 171. In control adipocyte ghosts, GTP 
(3 /rM) decreased the forskolin (50 FM)-stimulated 
activity, and addition of NaCl (150 mM) largely 
reversed this GTP-induced in~bition (table 1). In 
the presence of both GTP and NaCI, nicotinic acid 
(30~M) decreased the enzyme activity by -SO%, 
apparently by counteracting the NaCl-induced in- 
crease in activity [7,11]. In adipocyte ghosts from 
IAP-pretreated rats, however, the inhibitory effect 
of GTP was lost and NaCl no longer increased 
adenylate cyclase activity. Accordingly, nicotinic 
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Table 1 
Influence of IAP on rat adipocyte adenylate cyclase 
regulation by GTP, NaCl and nicotinic acid 
Additions Adenylate cyclase activity 
(pm01 CAMP. min-’ . mg 
protein-‘) 
Control IAP 
None 636 466 
GTP (3 FM) 220 466 
GTP + NaCl 
(150 mM) 551 477 
GTP + NaCl + 
uicotinic acid 
(30 FM) 269 477 
Adenylate cyclase activity was determined in adipocyte 
ghosts from rats pretreated with and without IAP as 
described insection 2. The incubation was for 15 min at 
25°C in the presence of SOpM forskolin with and 
without he additions indicated 
acid, at a concentration maximally effective in 
control membranes 171, had no inhibitory effect on 
the adipocyte adenylate cyclase from IAP- 
pretreated rats. 
The data obtained with GTP and GTPyS after 
ZAP treatment of whole animals and of intact rat 
adipocytes uggested that IAP may alter GTP 
hydrolysis in adipocyte membranes. Therefore, we 
studied the influence of IAP, purified to apparent 
homogeneity [ 121, on nicotinic arid-induced 
GTPase stimulation. Rat adipocyte ghosts were 
pretreated with and without purified IAP for 
10 min at 37OC. After a washing step, GTP 
hydrolysis was determined in these membranes. In
the absence of IAP in the pretreatment medium, 
nicotinic acid (30 PM) increased rat adipocyte high 
affinity GTPase activity by about 80% (fig.3) as in 
[lo]. With increasing concentrations of IAP in the 
pretreatment medium, the nicotinic acid-induced 
GTPase stimulation was decreased, whereas the 
‘basal’, unstimulated GTPase activity was only 
slightly affected. With 7 ,ug IAP in the preincuba- 
tion medium, the stimulatory effect of nicotinic 
acid was almost abolished. After finishing this 
study, inhibition of enkeph~ne-induced GTPase 
stimulation in neuroblastoma x glioma hybrid 
Volume 156, number I FEBS LETTERS June 1983 
1oL 
0’ 0.7 21 7 
I AP lpg) 
Fig.3. Influence of IAP on nicotinic acid-induced 
GTPase stimulation. Rat adipocyte ghosts were 
pretreated without and with purified IAP at the 
indicated concentrations @g/tube) as in section 2. After 
a washing step, GTPase activity was determined in these 
membranes without (control) and with 30 FM nicotinic 
acid as indicated. High affinity GTPase activity 
estimated as in [lo] is given on the ordinate. 
cells by IAP was reported [16]. In this regard, the 
data are in accordance with those shown herein for 
the effect of IAP in rat adipocytes. 
4. DISCUSSION 
There is increasing evidence that inhibition of 
adenylate cyclase by hormones and neurotransmit- 
ters is mediated by a guanine nucleotide-binding, 
regulatory component (Ni) that is distinct from 
that (N8) mediating adenylate cyclase stimulation 
by hormones and stable GTP analogs [17], Ni ap- 
parently also mediates adenylate cyclase inhibition 
by stable GTP analogs [9,18]. This assumption has 
been corroborated by findings in cyc- variants of 
S49 lymphoma cells. In these Ns-deficient cells, the 
adenylate cyclase can be inhibited by stable GTP 
analogs [ 14,151. In addition, the peptide hormone, 
somatostatin, inhibits the cyc- adenylate cyclase in 
a GTP-dependent manner [19]. Similar to N,- 
mediated adenylate cyclase stimulation, Nr- 
mediated adenylate cyclase inhibition induced by 
hormones is accompanied by an increased GTP 
hydrolysis as observed in membranes of human 
platelets [20], neuroblastoma x glioma hybrid cells 
[21], hamster and rat adipocytes [lO,l l] and S49 
lymphoma cells [22]. 
These data suggest hat the B. pertussis toxin, 
IAP, prevents Ni activation by GTP and hormonal 
factors, whereas Ni activation by the stable GTP 
analog, GTP+, is not impaired. Concomitantly, 
GTP and nicotinic acid-induced adenylate cyclase 
inhibition and nicotinic acid-induced GTPase 
stimulation are abolished, whereas GTPrS still in- 
hibits the adipocyte adenylate cyclase. Some data 
presented may also suggest hat GTP hydrolysis is 
required for Ni-mediated adenylate cyclase’inhidi- 
tion and IAP prevents GTP-dependent inhibition 
of adenylate cyclase by inhibition of Ni-associated 
GTPase stimulation. However, the data reported 
with stable GTP analogs in various cellular systems 
[8,9,14,15,18] and those shown herein with GTPyS 
in rat adipocytes are in apparent contradiction to 
this assumption. It may be speculated that stable 
GTP analogs not only act in a manner similar to 
GTP but that these analogs may have additional 
unknown effects on the adenylate cyclase system; 
e.g., causing conformational changes of the 
guanine nucleotide-binding coupling compo- 
nent(s). 
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